GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » PB Ratio

Cabio Biotech (Wuhan) Co (SHSE:688089) PB Ratio : 1.71 (As of Jun. 03, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-03), Cabio Biotech (Wuhan) Co's share price is ¥15.25. Cabio Biotech (Wuhan) Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥8.92. Hence, Cabio Biotech (Wuhan) Co's PB Ratio of today is 1.71.

The historical rank and industry rank for Cabio Biotech (Wuhan) Co's PB Ratio or its related term are showing as below:

SHSE:688089' s PB Ratio Range Over the Past 10 Years
Min: 1.34   Med: 3.59   Max: 9.27
Current: 1.71

During the past 11 years, Cabio Biotech (Wuhan) Co's highest PB Ratio was 9.27. The lowest was 1.34. And the median was 3.59.

SHSE:688089's PB Ratio is ranked better than
65.12% of 1313 companies
in the Biotechnology industry
Industry Median: 2.52 vs SHSE:688089: 1.71

During the past 12 months, Cabio Biotech (Wuhan) Co's average Book Value Per Share Growth Rate was 4.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 3.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 12.60% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Cabio Biotech (Wuhan) Co was 32.40% per year. The lowest was 3.80% per year. And the median was 19.45% per year.

Back to Basics: PB Ratio


Cabio Biotech (Wuhan) Co PB Ratio Historical Data

The historical data trend for Cabio Biotech (Wuhan) Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cabio Biotech (Wuhan) Co PB Ratio Chart

Cabio Biotech (Wuhan) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.58 3.61 5.34 3.83 2.04

Cabio Biotech (Wuhan) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.27 2.51 2.26 2.04 1.63

Competitive Comparison of Cabio Biotech (Wuhan) Co's PB Ratio

For the Biotechnology subindustry, Cabio Biotech (Wuhan) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cabio Biotech (Wuhan) Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cabio Biotech (Wuhan) Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Cabio Biotech (Wuhan) Co's PB Ratio falls into.



Cabio Biotech (Wuhan) Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Cabio Biotech (Wuhan) Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=15.25/8.916
=1.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Cabio Biotech (Wuhan) Co  (SHSE:688089) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Cabio Biotech (Wuhan) Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cabio Biotech (Wuhan) Co (SHSE:688089) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, CHN, 430073
Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.
Executives
Shang Yun Core technical personnel
Wang Hua Biao Directors, senior managers
Geng An Feng senior management
Du Bin Director
Yi Hua Rong senior management
Ma Tao senior management
Li Xiang Yu senior management
Wu Yu Jun Supervisors
Xiao Min senior management
Wang Zhi Ming senior management
Lu Shu Huan Core technical personnel
Yi De Wei Director

Cabio Biotech (Wuhan) Co (SHSE:688089) Headlines

No Headlines